Background: Ferns contain natural products with potential therapeutic applications. Current knowledge of the pharmacological properties of ferns, specifically those growing at high altitudes, is limited. This study aimed to evaluate the phytochemical contents as well as antibacterial, anti-glucosidase, and antioxidant activities of four highland ferns in Malaysia. Results: Aqueous extracts of the leaves and rhizomes of Cyathea latebrosa, Dicranopteris curranii, Gleichenia truncata, and Phymatopteris triloba were analysed. P. triloba leaf extract had the highest contents of total flavonoids (118.6 mg/g dry matter), hydroxycinnamic acids (69.7 mg/g dry matter), and proanthocyanidins (29.4 mg/g dry matter). P. triloba leaf and rhizome extracts as well as G. truncata leaf extract inhibited the growth of both Gram-positive and Gram-negative bacteria. P. triloba leaf extract produced a minimum inhibitory concentration (MIC) value of 0.78 mg dry matter/mL when tested against Pseudomonas aeruginosa, which is 2.5-fold higher than that of ampicillin. Among all extracts, P. triloba leaf extract had the highest anti-glucosidase activity (EC 50 = 56 μg dry matter/mL) and also the highest antioxidant potential based on DPPH radical scavenging and Ferric Reducing Antioxidant Power assays. Antioxidant activities of both the leaf and rhizome extracts correlated positively with total flavonoid and hydroxycinnamic acid contents (R 2 = 0.80-0.95). On the other hand, anti-glucosidase activity correlated with total proanthocyanidin contents in both the leaf and rhizome extracts (R 2 = 0.62-0.84).
Background
Ferns are a rich source of natural products with therapeutic potential. Bioactive constituents of ferns exhibit diverse pharmacological properties, which include antioxidant, antibacterial, anti-tumour, and anti-inflammatory activities (Ho et al. 2010) . While the bioactivities of ferns have been previously investigated, little attention has been given to highland ferns. Plants growing at high altitudes are known to produce increased levels of phenolic compounds and exhibit enhanced antioxidant activity (Spitaler et al. 2008; Rawat et al. 2011) . Hence, highland ferns may be a rich source of bioactive natural products.
Cyathea latebrosa (Family Cyatheaceae), Dicranopteris curranii (Family Gleicheniaceae), Gleichenia truncata (Family Gleicheniaceae), and Phymatopteris triloba (Family Polypodiaceae) are four highland ferns which occur not only in Malaysia, but also the rest of South-east Asia (Holttum 1966; Piggott 1988) . There is no documentation in the literature of the uses of these four ferns as therapeutic agents. Notably, some species in the genera of Cyathea, Dicranopteris, Gleichenia and Phymatopteris are used as traditional remedies for various diseases (Ho et al. 2010; Su et al. 2011) . Hence, we endeavoured to fill the gaps in current knowledge about the therapeutic potential of C. latebrosa, D. curranii, G. truncata and P. triloba.
Current interest in searching for therapeutic agents of plant origin is partially promoted by concerns about the side effects of conventional therapeutic agents. For example, existing glucosidase inhibitors (e.g. Acarbose) used in the management of diabetes cause side effects, such as flatulence and diarrhoea (Kumar et al. 2012) . Concerns about the toxicity of synthetic antioxidants are also driving current interest in searching for natural antioxidants (Razab and Aziz 2010) . Moreover, there is an urgent need for finding new antibacterial agents due to the increased incidence of bacterial resistance against conventional antibiotics (Daglia 2012) .
At present, the phytochemical profiles of C. latebrosa, D. curranii, G. truncata and P. triloba are unknown. However, previous studies have shown that bioactive constituents of ferns mainly belong to the families of phenolics, terpenoids, and alkaloids (Ho et al. 2010) . Flavonoids, hydroxycinnamic acids, and proanthocyanidins are important classes of health-promoting phenolic phytochemicals (El Gharras 2009). The antibacterial, anti-glucosidase, antioxidant, and other bioactive effects of these phytochemicals were previously reviewed (Cushnie and Lamb 2005; El Gharras 2009; Kumar et al. 2011) . Hence, the goal of our study was two-fold: (1) To evaluate the antibacterial, anti-glucosidase, and antioxidant activities of the leaf and rhizome extracts of C. latebrosa, D. curranii, G. truncata, and P. triloba; and (2) to determine whether such activities can be attributed to the contents of flavonoids, hydroxycinnamic acids, and proanthocyanidins in the extracts.
Methods

Plant material
Leaf and rhizome samples of four fern species, namely Cyathea latebrosa (Wall. ex. Hook) Copel., Dicranopteris curranii Copel., Gleichenia truncata (Willd.) Spreng., and Phymatopteris triloba (Houtt.) Pichi Serm., were collected from Cameron Highlands, Malaysia, in January 2012. Collection site elevation is 1495 m. The species of the ferns were authenticated by H.-C. Ong. Voucher specimens of C. latebrosa, D. curranii, G. truncata, and P. triloba (numbered TTC01/2012(1), TTC01/2012(2), TTC01/2012(3), and TTC01/2012(4), respectively) were deposited at the Department of Chemical Science, Universiti Tunku Abdul Rahman, for future reference.
Preparation of aqueous extracts
The leaf and rhizome samples were cleaned and then oven-dried at 45°C for 72 h. The dried samples were ground to powder using a Waring blender. Extracts were prepared by mixing the pulverised samples with autoclaved deionised water at a 1:20 (dry weight: volume) ratio and then incubating the mixture at 90°C for 60 min (Kumaran and Joel karunakaran 2006) . The extracts were clarified by vacuum-filtration followed by centrifugation at 8600 g and 4°C for 10 min. The supernatant obtained, taken as 50 mg dry matter (DM)/mL, was aliquoted (500 μL each) and stored at −20°C until used.
Determination of total flavonoid, hydroxycinnamic acid, and proanthocyanidin contents Total flavonoid (TF) content was determined using an aluminium chloride colorimetric assay (Chai and Wong 2012) . TF content was expressed as mg catechin equivalents (CE)/g DM, calculated from a standard curve prepared with 0-300 μg catechin/mL. Total hydroxycinnamic acid (TH) content was determined using the Arnow's reagent (Matkowski et al. 2008) . TH content was expressed as mg caffeic acid equivalents (CAE)/g DM, calculated from a standard curve prepared with 0-200 μg caffeic acid/mL. Total proanthocyanidin (TPR) content was assessed based on the acid-butanol assay (Porter et al. 1986 ). TPR content was calculated with the assumption that effective E 1%, 1 cm, 550 nm of leucocyanidin is 460 and expressed as mg leucocyanidin equivalents (LE)/g DM.
Determination of antibacterial activity
Minimum Inhibitory Concentration (MIC) assay was carried out to determine the lowest extract concentration required to inhibit bacterial growth. The assay was performed based on published protocols (Andrews 2001; Wiegand et al. 2008 ) with slight modifications. Two Gram-positive bacteria (Staphylococcus aureus and Micrococcus luteus) and two Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa) were used in the assay. Briefly, a bacterial inoculum of 5 × 10 5 colony-forming unit/mL was prepared in MuellerHinton Broth and aliquoted into a 96-well sterile microtiter plate. Plant extract was added into the first row of wells, serially diluted to final concentrations of 50. 00, 25.00, 12.50, 6.25, 3.13, 1.56, 0.78, and 0 .40 mg/mL. The plate was then sealed and incubated at 37°C for 24 h. Next, 20 μL of p-iodonitrotetrazolium chloride (0.4 mg/mL) was added to each well, followed by 30 min of incubation at 37°C. Colour change in each well was monitored visually. The lowest extract concentration that inhibited bacterial growth, indicated by the absence of colour change in the well, was taken as the MIC value. For comparison, the assay was carried out using different concentrations of ampicillin (2.50, 1.25, 0.63, 0.31, 0.16, 0.08, 0.04, and 0.02 mg/mL).
Determination of glucosidase inhibitory activity
Glucosidase inhibitory activity was assessed as previously described (Sancheti et al. 2011 ) with minor modifications. A reaction mixture containing 250 μL of 100 mM potassium phosphate buffer (pH 7.0), 150 μL of 0.5 mM 4-nitrophenyl α-D-glucopyranoside, 50 μL of extract, and 150 μL of α-glucosidase (from Saccharomyces cerevisiae; 0.1 unit/mL in 10 mM potassium phosphate buffer, pH 7.0) was incubated at 37°C for 30 min. The reaction was ended by adding 600 μL of 200 mM Na 2 CO 3 . The absorbance reading was taken at 400 nm. A blank was prepared for each measurement by replacing α-glucosidase with 10 mM potassium phosphate buffer. Anti-glucosidase activity (%) was calculated using the following equation:
where A control is the absorbance of control reaction (without extract) and A sample is the absorbance in the presence of an extract. Quercetin, which is an effective α-glucosidase inhibitor in vitro and in vivo (Jo et al. 2009; Fontana Pereira et al. 2011; Kim et al. 2011) , was used as the positive control. EC 50 value, defined as the concentration of extract or quercetin required to achieve 50% anti-glucosidase activity, was determined using linear regression analysis.
Determination of 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity DPPH radical scavenging assay was carried out as previously described (Chai and Wong 2012) . Ascorbic acid was used as the positive control. EC 50 value, which is the concentration of extract or ascorbic acid required to achieve 50% DPPH scavenging activity, was determined using linear regression analysis.
Determination of Ferric Reducing Antioxidant Power (FRAP)
Ferric reducing activity of the extracts was determined with the FRAP assay (Benzie and Strain 1996) . The FRAP reagent consisted of acetate buffer (300 mM, pH 3.6), 2,4,6-tripyridyl-s-triazine (10 mM), and FeCl 3 .6H 2 O (20 mM) in a 10:1:1 (v:v:v) ratio. A reaction mixture containing 0.2 mL of extract and 1.2 mL of FRAP reagent was incubated at 37°C for 5 min. Absorbance of the mixture was then read at 593 nm. FRAP values are presented in mM Fe 2+ equivalents, calculated from a standard curve prepared with 0 to 0.40 mM FeSO 4 .7H 2 O. Ascorbic acid was used as the positive control.
Data analysis
All experiments were carried out in triplicates and data are reported as mean ± standard errors. Statistical analyses were performed using SAS (Version 9.2). Data were analysed by the ANOVA test and means of significant differences were separated using Fisher's Least Significant Difference (LSD) test at the 0.05 level of probability. Linear regression and correlation analyses were carried out using Microsoft Office Excel 2003.
Results
The leaf extract of P. triloba had the highest TF, TH, and TPR contents compared with all other extracts (Table 1) . TPR content of P. triloba leaf extract was 21-fold higher compared with C. latebrosa leaf extract. Among the rhizome extracts, P. triloba had the highest TF, TH, and TPR contents, whereas C. latebrosa had the lowest. TF content of the rhizome extract of P. triloba was 14-fold higher than that in C. latebrosa rhizome extract.
Antibacterial assays found that the lowest MIC values were consistently observed for the leaf and rhizome extracts of P. triloba (Table 2 ). Among the leaf extracts, only P. triloba and G. truncata inhibited the growth of Gramnegative bacteria over the range of extract concentrations tested. When tested on P. aeruginosa and S. aureus, the leaf extract of P. triloba produced MIC values that were 2.5-fold and 39-fold higher compared with ampicillin. Among rhizome extracts, P. triloba, G. truncata, and D. curranii were all inhibitory to Gram-positive bacteria but only P. triloba was inhibitory to Gram-negative bacteria. The rhizome extract of P. triloba produced MIC values that were 10-fold and 104-fold higher than those of ampicillin when tested on P. aeruginosa and S. aureus.
Among the leaf extracts, P. triloba had the highest glucosidase inhibitory activity, while C. latebrosa had the lowest (Figure 1) . The EC 50 values of the leaf extracts were 56 (P. triloba), 143 (D. curranii), 408 (G. truncata), and 1413 μg DM/mL (C. latebrosa). Among the rhizome extracts, C. latebrosa had the lowest anti-glucosidase activity, whereas the other three fern species showed similar levels of anti-glucosidase activities. The EC 50 values of the rhizome extracts were 175 (G. truncata), 179 (D. curranii), 191 (P. triloba), and 755 μg DM/mL (C. latebrosa). The EC 50 value of quercetin was 22 μg/mL. DPPH scavenging activity of the leaf and rhizome extracts increased in a concentration-dependent manner over the range of concentrations tested (Figure 2) . Based on the DPPH scavenging assay, EC 50 values of the leaf extracts were 73 (P. triloba), 79 (C. latebrosa), 116 (G. truncata), and 144 μg DM/mL (D. curranii). There was no significant difference (p > 0.05) between the EC 50 values of P. triloba and C. latebrosa leaf extracts. EC 50 values of the rhizome extracts were 97 (P. triloba), 133 (G. truncata), 148 (D. curranii), and 383 μg DM/mL (C. latebrosa). There was no significant difference (p > 0.05) between the EC 50 values of G. truncata and D. curranii rhizome extracts. EC 50 value of ascorbic acid, the positive control, was 5 μg/mL.
FRAP values of leaf and rhizome extracts increased almost linearly with increasing extract concentrations (Figure 3) . The ferric reducing power of leaf and rhizome extracts was lower compared with ascorbic acid. When expressed on the basis of dry mass of plant powder, FRAP values of the leaf extracts in descending order were 696 (P. triloba), 571 (C. latebrosa), 483 (G. truncata), and 305 μmol Fe 2+ equivalents/g DM (D. curranii). FRAP values of the rhizome extracts were 338 (P. triloba), 281 (G. truncata), 274 (D. curranii), and 39 μmol Fe 2+ equivalents/g DM (C. latebrosa). There was no significant difference (p > 0.05) between the FRAP values of G. truncata and D. curranii rhizome extracts.
The strength of correlation between phytochemical contents (TF, TH, and TPR) and the EC 50 values of antiglucosidase and DPPH scavenging activities of the fern extracts was analysed. Anti-glucosidase activities of the leaf extracts correlated only with TPR contents (Table 3) 
Discussion
In this study, P. triloba leaf and rhizome extracts as well as G. truncata leaf extract inhibited the growth of both Gram-positive and Gram-negative bacteria. Notably, when tested against P. aeruginosa, comparable MIC values were obtained for P. triloba leaf extract and ampicillin. This suggests that P. triloba and G. truncata are potential sources of broad-spectrum antibacterial agents. In contrast to Gram-negative bacteria, Gram-positive bacteria were more sensitive to the inhibitory effects of the fern extracts. Similar observations were made in other studies which evaluated the antibacterial efficacy of ferns and other plants (Chew et al. 2009; Lai et al. 2009 ). The insensitivity of Gram-negative bacteria against antibacterial agents is attributable to the permeability barrier posed by the outer membrane of the bacteria and efficient multidrug efflux pumps traversing the bacterial membranes (Delcour 2009; Li and Nikaido 2009) . Whether bioactive constituents of P. triloba and G. truncata can compromise these mechanisms in Gram-negative bacteria is currently unclear.
P. triloba leaf and rhizome extracts had the highest TF and TPR contents among the fern extracts. Flavonoids may exert antibacterial activity by inhibiting bacterial nucleic acid synthesis, energy metabolism, and cytoplasmic membrane functions (Cushnie and Lamb 2005) . Plant-derived proanthocyanidins may inhibit the growth of pathogenic bacteria by binding strongly to proteins at bacterial cell surfaces (Xu et al. 2012) . Hence, flavonoids, specifically proanthocyanidins, may be key determinants of the antibacterial effects of P. triloba. P. triloba leaf extract exhibited the highest glucosidase inhibitory activity among the fern extracts examined. Flavonoids, hydroxycinnamic acids, and proanthocyanidins as well as polyphenol extracts of plant origin are known to inhibit α-glucosidase activity in vitro (Hanhineva et al. 2010) . Hence, the high TF, TH, and TPR contents of P. triloba leaf extract may partially account for its potent anti-glucosidase activity. Notably, the positive correlation between TPR content and anti-glucosidase activity in both leaf and rhizome extracts suggests that high TPR content may be an indicator of high antiglucosidase activity in highland ferns.
Our study suggests that the four highland ferns investigated are potential sources of water-soluble antioxidants. P. triloba is the most promising source of natural antioxidants among the four fern species. Correlation analyses suggest that flavonoids and hydroxycinnamic acid derivatives may be the key phenolic constituents responsible for the antioxidant activity of the fern extracts. This agrees with the findings of earlier studies on some medicinal plants (Matkowski et al. 2008; Chai and Wong 2012) . Flavonoids and hydroxycinnamic acids are known to exhibit antioxidant activity (Maurya and Devasagayam 2010; Procházková et al. 2011 ). In our study, TF and TH contents of leaf extracts were generally higher compared with rhizome extracts. This may explain why the leaf extracts showed higher levels of antioxidant activity compared with rhizome extracts. Our findings also imply that high TF and TH contents may be an indicator of high antioxidant activity in ferns and possibly other plants growing at high altitudes.
Conclusion
In conclusion, aqueous extracts of highland ferns are potential sources of antibacterial agents, glucosidase inhibitors, and antioxidants. Our in vitro investigations found that P. triloba leaf extract exhibited the highest anti-bacterial, anti-glucosidase, and antioxidant activities among all extracts examined. Phytochemical analyses revealed that P. triloba leaf extract had the highest contents of flavonoids, hydroxycinnamic acids, and proanthocyanidins. Correlation analysis suggests antioxidant activities of both the leaf and rhizome extracts may be attributed to their flavonoid and hydroxycinnamic acid contents. On the other hand, anti-glucosidase activity was attributable to total proanthocyanidin contents in both the leaf and rhizome extracts. Optimisation of extraction of bioactive components from P. triloba, chemical characterisation of such compounds, and further testing of their effects in vivo are warranted in future investigations. Values presented are statistically significant (p < 0.05). ns, not statistically significant.
